Suchergebnisse - "Guerriaud, Mathieu"

PubPharm (16)

1

Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidate

enthalten in: Gene therapy | 2024

von Guerriaud, M. | Poupet, C. | Lakhrif, Z. | +2

2

"Regulatory Sandboxes" Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal Products

enthalten in: Pharmaceutical medicine | 2024

von Guerriaud, M.

3

The Proposal for a Directive on Defective Products : A Game Changer for Innovative Medicinal Products

enthalten in: European journal of health law | 2024

von Guerriaud, M. | Siranyan, V.

4

“Regulatory Sandboxes” Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal Products

enthalten in: Pharmaceutical medicine | 2023

von Guerriaud, M.

5

Why is there no biosimilar of Erbitux®?

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Douez, E. | D'Atri, V. | Guillarme, D. | +5

6

RNA-based drugs and regulation : Toward a necessary evolution of the definitions issued from the European union legislation

enthalten in: Frontiers in medicine | 2022

von Guerriaud, M. | Kohli, E.

7

The pharmacist and informed consent

enthalten in: Actualites pharmaceutiques | 2021

von Mrozovski, J. | Guerriaud, M.

8

enthalten in: Actualites pharmaceutiques | 2021

von Guerriaud, M.

9

Low Cross-Reactivity Between Cisplatin and Other Platinum Salts

enthalten in: The journal of allergy and clinical immunology. In practice | 2019

von Pasteur, J. | Favier, L. | Pernot, C. | +6

10

Studying at École de pharmacie de Lille with Alfred Giard in the XIXth century

enthalten in: Revue d'histoire de la pharmacie | 2015

von Guerriaud, M.